NCT07132645
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
Clinical trial condition
Neuroendocrine Tumor
Explore clinical trials studying Neuroendocrine Tumor. Study availability and eligibility vary by location and protocol.
31 public trials
5 recruiting studies
Neuroendocrine Tumor trial results
NCT06788886
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +28 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT04907643
- Conditions
- Adenocarcinoma, Ampullary Cancer, Anal Cancer, +128 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
NCT04837885
- Conditions
- Liver Metastases, Neoplasms, Neoplasms by Histologic Type, +6 more
- Locations
-
- Institut Bergonié Bordeaux, France
- Institut de cancérologie du Gard (ICG) - CHU de Nîmes Nîmes, France
- CHU Bordeaux - Hôpital Haut Lévêque Pessac, France
- Institut universitaire du cancer de Toulouse (IUCT) Oncopole Toulouse, France
NCT05069220
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +11 more
- Locations
-
- Peking union medical college hospital Beijing, Dongcheng, China
Enrolling by invitation
RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide
NCT02270567
- Conditions
- Adenocarcinoma, Carcinoid, Carcinoid Tumor, +15 more
- Locations
-
- Wren Laboratories Branford, Connecticut, United States
Active, not recruiting
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
NCT03375320
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +42 more
- Locations
-
- Katmai Oncology Group Anchorage, Alaska, United States
- Kingman Regional Medical Center Kingman, Arizona, United States
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Active, not recruiting
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
NCT00569127
- Conditions
- Colorectal Neuroendocrine Tumor G1, Gastric Neuroendocrine Tumor G1, Neoplasms, +8 more
- Locations
-
- Providence Hospital Mobile, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
Active, not recruiting
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
NCT02628067
- Conditions
- Adenocarcinoma, Adenoma, Advanced Cancer, +88 more
- Locations
-
Not specified
Completed
Surgical Intervention and the NETest
NCT03012789
- Conditions
- Gastroenteropancreatic, Neoplasms, Neoplasms by Histologic Type, +5 more
- Locations
-
- San Raffaele Hospital IRCCS Milan, Italy